Induced hypertension and hypervolemia for treatment of cerebral vasospasm
- PMID: 2136148
Induced hypertension and hypervolemia for treatment of cerebral vasospasm
Abstract
The authors discuss a comprehensive management program for patients with cerebral vasospasm following subarachnoid hemorrhage in which therapeutic manipulation and meticulous monitoring of a number of physiologic determinants of cardiac function are employed. Ventricular preload is most significantly affected by hypervolemic therapy, but alternate methods of reversing ischemic neurologic deficits with various inatropic agents are discussed also.
Similar articles
-
Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.Acta Neurochir (Wien). 2002 Jul;144(7):703-12; discussion 712-3. doi: 10.1007/s00701-002-0959-9. Acta Neurochir (Wien). 2002. PMID: 12181704
-
Cardiac performance enhancement and hypervolemic therapy.Neurosurg Clin N Am. 1994 Oct;5(4):725-39. Neurosurg Clin N Am. 1994. PMID: 7827481 Review.
-
Cerebral blood measurements in vasospasm.Neurosurg Clin N Am. 1990 Apr;1(2):307-18. Neurosurg Clin N Am. 1990. PMID: 2136143 Review.
-
[Serious pitfalls which can be encountered in a course of hypertension-hypervolemia therapy for vasospasm].No Shinkei Geka. 1992 Apr;20(4):357-65. No Shinkei Geka. 1992. PMID: 1570056 Japanese.
-
Vasomotion, regional cerebral blood flow and intracranial pressure after induced subarachnoid haemorrhage in rats.Zentralbl Neurochir. 1996;57(3):150-5. Zentralbl Neurochir. 1996. PMID: 8794547
Cited by
-
Cerebral vasospasm and concurrent left ventricular outflow tract obstruction: requirement for modification of hyperdynamic therapy regimen.Neurocrit Care. 2010 Apr;12(2):265-8. doi: 10.1007/s12028-009-9286-9. Neurocrit Care. 2010. PMID: 19816811
Publication types
MeSH terms
LinkOut - more resources
Medical